Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 13, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 44
- +7 vs. Q1 2021
- Portfolio value
- $157.9M
- +$35.8M (+29.3%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 422,000 | $21.7M | 13.7% | −178,000−29.7% | Reduced | History |
| ALBOAlbireo Pharma, Inc. | COM | 295,080 | $10.4M | 6.6% | +124,728+73.2% | Added | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 137,000 | $9.34M | 5.9% | +31,172+29.5% | Added | History |
| HAEHaemonetics Corp | COM | 134,000 | $8.93M | 5.7% | +134,000 | New | History |
| CUECue Biopharma, Inc. | COM | 630,364 | $7.34M | 4.7% | +73,587+13.2% | Added | History |
| EHCEncompass Health Corp | COM | 88,000 | $6.87M | 4.3% | −12,000−12.0% | Reduced | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 595,239 | $6.74M | 4.3% | +121,793+25.7% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 1,023,704 | $5.56M | 3.5% | +273,394+36.4% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 27,100 | $5.46M | 3.5% | −11,250−29.3% | Reduced | History |
| XCURExicure, Inc. | COM | 3,600,000 | $5.40M | 3.4% | +3,324,152+1,205.1% | Added | History |
| ZGNXZogenix, Inc. | COM NEW | 305,788 | $5.28M | 3.3% | +110,788+56.8% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 31,500 | $5.07M | 3.2% | +10,303+48.6% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 72,000 | $4.96M | 3.1% | +5,581+8.4% | Added | History |
| CNVYConvey Health Solutions Holdings, Inc. | COM | 410,412 | $4.67M | 3.0% | +410,412 | New | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 181,171 | $4.34M | 2.7% | +181,171 | New | History |
| MGTXMeiraGTx Holdings plc | COM | 273,523 | $4.24M | 2.7% | −18,421−6.3% | Reduced | History |
| RCMR1 RCM Holdco Inc. | COM | 171,817 | $3.82M | 2.4% | +171,817 | New | History |
| MORFMorphic Holding, Inc. | COM | 64,292 | $3.69M | 2.3% | +59,090+1,135.9% | Added | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 138,886 | $3.61M | 2.3% | +138,886 | New | History |
| MTCRMetacrine, Inc. | COM | 869,082 | $3.30M | 2.1% | +564,597+185.4% | Added | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 420,000 | $2.83M | 1.8% | −30,165−6.7% | Reduced | History |
| QSIQuantum-Si Inc | COM CL A | 227,391 | $2.79M | 1.8% | +227,391 | New | History |
| UNHUnitedHealth Group Inc | Stock | 5,000 | $2.00M | 1.3% | −1,000−16.7% | Reduced | History |
| LHCGLHC Group, Inc | COM | 9,888 | $1.98M | 1.3% | +1,105+12.6% | Added | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 130,000 | $1.69M | 1.1% | −230,834−64.0% | Reduced | History |
| ATIPATI Physical Therapy, Inc. | COM CL A | 173,276 | $1.65M | 1.0% | +173,276 | New | History |
| MDTMedtronic plc | Stock | 11,000 | $1.36M | 0.9% | −9,088−45.2% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 20,200 | $1.34M | 0.8% | +20,200 | New | History |
| CLLSCellectis S.A. | SPON ADS | 86,036 | $1.33M | 0.8% | −51,864−37.6% | Reduced | History |
| OSCROscar Health, Inc. | CL A | 55,000 | $1.18M | 0.7% | −52,086−48.6% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 52,023 | $1.10M | 0.7% | +52,023 | New | History |
| CLOVClover Health Investments, Corp. | COM CL A | 79,100 | $1.05M | 0.7% | +79,100 | New | History |
| AKUAkumin Inc. | COM | 327,680 | $1.03M | 0.7% | −101,381−23.6% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 91,694 | $854.0K | 0.5% | +91,694 | New | History |
| SIOXSio Gene Therapies Inc. | COMMON | 256,115 | $699.0K | 0.4% | +50,215+24.4% | Added | History |
| ONCROncorus, Inc. | COM | 50,000 | $690.0K | 0.4% | −20,807−29.4% | Reduced | History |
| OPCHOption Care Health, Inc. | COM NEW | 27,875 | $610.0K | 0.4% | +27,875 | New | History |
| ASMBAssembly Biosciences, Inc. | COM | 149,090 | $578.0K | 0.4% | +92,590+163.9% | Added | History |
| XFORX4 Pharmaceuticals, Inc | COM | 87,813 | $571.0K | 0.4% | +87,813 | New | History |
| OKUROnKure Therapeutics, Inc. | COM | 54,934 | $513.0K | 0.3% | +54,934 | New | History |
| APTOAptose Biosciences Inc. | COM NEW | 133,000 | $442.0K | 0.3% | −17,000−11.3% | Reduced | History |
| ORGOOrganogenesis Holdings Inc. | COM | 25,100 | $417.0K | 0.3% | +9,868+64.8% | Added | History |
| CANOCano Health, Inc. | COM CL A | 23,200 | $281.0K | 0.2% | +23,200 | New | History |
| ADMAAdma Biologics, Inc. | COM | 115,100 | $184.0K | 0.1% | −382,742−76.9% | Reduced | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Albireo Pharma Inc01345P906 | CALL | – | $1.16M |
| Aurinia Pharmaceuticals Inc05156V902 | CALL | – | $871.0K |
Sold out since Q1 2021 (8)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 95,600 | $6.04M | 4.9% | History |
| INOVInovalon Holdings, Inc. | COM CL A | 85,000 | $2.45M | 2.0% | History |
| TVRDTvardi Therapeutics, Inc. | COM | 100,000 | $2.17M | 1.8% | History |
| SLDBSolid Biosciences Inc. | COM | 320,100 | $1.77M | 1.4% | History |
| BEAMBeam Therapeutics Inc. | COM | 17,000 | $1.36M | 1.1% | History |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 8,685 | $1.33M | 1.1% | History |
| BAXBaxter International Inc | Stock | 5,800 | $489.0K | 0.4% | History |
| ODTOdonate Therapeutics, Inc. | COM | 117,621 | $402.0K | 0.3% | History |